PRINCIPAL FINANCIAL GROUP INC
Position in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 1126328
DES MOINES, IA
Position in MDGL
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$648,579
-$3,579,791 QoQ
Shares Held
1,239
-82.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in MDGL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $648,579 | 1,239 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $4,228,370 | 7,261 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $5,535,108 | 12,068 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $2,786,103 | 9,206 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $474,983 | 1,434 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $472,112 | 1,530 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $345,069 | 1,626 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $856,168 | 3,056 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $1,068,693 | 4,002 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $896,596 | 3,875 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $545,167 | 3,733 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $880,341 | 3,811 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $952,081 | 3,930 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,218,179 | 4,197 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $248,976 | 3,831 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $278,875 | 3,896 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $209,780 | 2,138 | Shares | Defined | 2022-05-09 | |
| 2021-09-30 | $254,051 | 3,184 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $360,319 | 3,699 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $625,321 | 5,346 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $601,095 | 5,407 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $383,022 | 3,226 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $383,011 | 3,382 | Shares | Defined | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||